bpc 157 psoriasis SynaPep™ BPC-157 Treatment Psoriasis: A Disease of Systemic
Description
Adjust dose based on response and tolerance
Long-term Effects : More extensive longitudinal studies are necessary to thoroughly understand long-term safety implications
Click here to learn more about BPC-157 protocol and dosing
Because it is essentially water without sufficient solute, direct intravenous administration can cause red blood cell lysis (hemolysis) due to its hypotonic nature
A cross-sectional study of non-smoking healthy adults, between 60 and 85 years old, showed no difference in the permeability index (PI= lactulose/mannitol) between young and older humans
